Mortality and IgA Nephropathy
In the recent study “Mortality in Patients with IgA Nephropathy” published in AJKD, Knoop et al describe the clinical outcomes of patients diagnosed with IgA [...]
ESRD
Dialysis Bicarbonate Concentration: Do We Know the Right Amount?
Bicarbonate is the principal buffer in dialysate, but only few studies have assessed outcomes of patients treated with different dialysate bicarbonate (DB) concentrations. A [...]
Weekend admissions of dialysis patients?— Oh No!!
Hospital admissions over weekends have been associated with worse outcomes in a variety of patient populations. The cause for this remains unclear. Authors of a recent study [...]
ATC 2013: Long-term Risk of ESRD in Kidney Donors – Is There Really No Harm?
Long-term Risk of ESRD in Kidney Donors: Is There Really No Harm? One of the most shocking presentations in the ATC was given during the last plenary session. Dr. Muzaale [...]
Body Mass Index, CKD and ESRD: Is There a Link?
In an article published in March issue of the American Journal of Kidney Diseases, the association between race, body mass index (BMI), and progression to end-stage renal [...]
Ferric Citrate and Hyperphosphatemia
AJKD recently published an article from Dwyer et al on a dose-response and safety/tolerability trial of a novel phosphorous binder, ferric citrate, for dialysis patients. [...]
Latent Tuberculosis in ESRD
The diagnosis of latent tuberculosis (TB) is important in patients with ESRD as the rate of activation is 50 times that of the general population. Additionally, some dialysis [...]
Denosumab in Chronic Kidney Disease
Denosumab is novel agent used to treat osteoporosis and prevent fractures associated with malignancies. Not much literature exists on use of this agent in advanced chronic [...]
Oral Nutrition During the Dialysis Treatment: Does It Make a Difference?
Optimal nutrition in the dialysis patient is a critical component of nephrology care since malnutrition carries a high risk of mortality, even when all other co-morbitites [...]
Dialysis Modality Selection in the 21st Century
In the August issue of the American Journal of Kidney Diseases, Hornberger and Hirth from Stanford University School of Medicine, University of Michigan, and Cedar Associates [...]